Form 4 for NEOG NEOGEN CORP
Accepted 2021-09-30 00:00:00 ET · period of report 2021-09-30 · accession 0000711377-21-000021 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-30 | 2021-09-30 | NEOG | Lilly Jason Warren | VP | M - OptEx | $20.23 | +16.0K | 36.0K | +80% | +$323.6K |
| D | 2021-09-30 | 2021-09-30 | NEOG | Lilly Jason Warren | VP | S - Sale+OE | $43.72 | -16.0K | 20.0K | -44% | -$699.4K |
| D | 2021-09-30 | 2021-09-30 | NEOG | Lilly Jason Warren | VP | M - OptEx | $0.00 | -16.0K | 148.3K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-30 | M | A | 15,998 | $20.23 | 35,998 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-30 | S | D | 15,998 | $43.72 | 20,000 | D | — | — | |
| 3 | Derivative | Common Stock (Right to Buy) | 2021-09-30 | M | D | 15,998 | $0.00 | 148,258 | D | $20.23 · 2021-09-29 to 2021-10-29 | 15,998 Common Stock |